Epilepsy affects nearly 50 million people globally, making it one of the most common neurological disorders, with about 80% of cases occurring in low- and middle-income countries where diagnostic and treatment resources are limited. Yet with timely and appropriate care, up to 70% of individuals with epilepsy can become seizure-free, underscoring the transformative impact of accurate diagnosis and effective treatment. According to DelveInsight’s estimates, in 2023, there were approximately 7 million prevalent cases of epilepsy in the 7MM. Of these, the US accounted for 48% of the cases.
Central to improving outcomes is effective monitoring, which provides essential ...
